Factors affecting the healing of chronic wounds: An iconoclastic view

Microbiology of Wounds

Volumn , Issue , 2010, Pages 345-372

  Carter, Marissa J ^a   Fife, Caroline E ^b,c  

^a Strategic Solutions Inc   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c Memorial Hermann Center for Wound Healing   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84904976008     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420079944     Document Type: Chapter

References (105)

1. Paré, A. (1571). Journeys in diverse places. In The Harvard classics, ed. C. W, Eliot, trans. S. Paget, Vol. 38, Part 2. New York: P.F. Collier & Son, 1909-14; Bartleby.com, 2001. http://www.bartleby.com/38/2/.
2. Glimore, O. J. (1977). 150 years after. A tribute to Joseph Lister. Ann R Coll Surg Engl 59:199-204.
3. Singer, M., and P. Glynne. (2005). Treating critical illness: The importance of first doing no harm. PLoS Med 2:e167.
4. Maclean A. A., A. M. O’Neill, H. L. Pachter, and M. A. Miglietta. (2006). Devastating consequences of subway accidents: Traumatic amputations. Am Surg 72:74-76.
5. Witkowski, J. E., and L. C. Parish. (1982). Histopathology of the decubitus ulcer. J Am Acad Dermatol 6:1014-1021.
6. Daniel, R. K., D. Wheatley, and D. Priest. (1985). Pressure sores and paraplegia. Ann Plast Surg 15:41-49.
7. Nola, G. T., and L. M. Vistnes. (1980). Differential response of skin and muscle in the experimental production of pressure sores. Plast Reconstr Surg 66:728-733.
8. Zulkowski, K., D. Langemo, and M. E. Posthauer. (2005). Coming to consensus on deep tissue injury. Adv Skin Wound Care 18:28-29.
9. Black, J., M. M. Baharestani, and J. Cuddigan, et al. (2007). National Pressure Ulcer Advisory Panel’s updated pressure ulcer staging system. Adv Skin Wound Care 20:269-274.
10. Barczak, C. A., R. I. Barnett, E. J. Childs, and L. M. Boslev. (1997). Fourth national pressure ulcer survey. Adv Wound Care 10:18-26.
11. Coleman, E. A., J. M. Martau, M. K. Lin, and A. M. Kramer. (2002). Pressure ulcer prevalence in long-term nursing home residents since the implementation of OBRA '87. Omnibus Budget Reconciliation Act. J Am Geriatr Soc 50:728-732.
12. Spector, W. D., and R. H. Fortinsky. (1998). Pressure ulcer prevalence in Ohio nursing homes: Clinical and facility correlates. J Aging Health 10:62-80.
13. Lahmann, N. A., R. J. Halfens, and T. Dassen. (2006). Pressure ulcers in German nursing homes and acute care hospitals: Prevalence, frequency, and ulcer characteristics. Ostomy Wound Manage 52:20-33.
14. Barrois, B., C. Labalette, and P. Rousseau, et al. (2008). A national prevalence study of pressure ulcers in French hospital inpatients. J Wound Care 17:373-376, 378-379.
15. Glass, A. G., J. V. Lacey, Jr, J. D. Carreon, and R. N. Hoover. (2007). Breast cancer incidence, 1980-2006: Combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 99:1152-1161.
16. Robson, M. C., and J. P. Heggers. (1969). Bacterial quantification of open wounds. Mil Med 134:19-24.
17. Schraibman, I. G. (1990). The significance of beta-haemolytic streptococci in chronic leg ulcers. Ann R Coll Surg Engl 72:123-124.
18. Gardner, S. E., R. A. Frantz, and B. N. Doebbeling. (2001). The validity of the clinical signs and symptoms used to identify localized chronic wound infection. Wound Repair Regen 9:178-186.
19. Nelson, E. A., S. O’Meara, and D. Craig, et al. (2006). A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers. Health Technol Assess 10:1-221.
20. Serena, T., M. C. Robson, D. M. Cooper, and J. Ignatius. (2006). Lack of reliability of clinical/visual assessment of chronic wound infection: The incidence of biopsy-proven infection in venous leg ulcers. Wounds 18:197-202.
21. Gardner, S. E., R. A. Frantz, C. L. Saltzman, S. L. Hillis, H. Park, and M. Scherubel. (2006). Diagnostic validity of three swab techniques for identifying chronic wound infection. Wound Repair Regen 14:548-557.
22. Levine, N. S., R. B. Lindberg, A. D. Mason, and B. A. Pruitt. (1976). The quantitative swab culture and smear: a quick, simple method for determining the number of viable aerobic bacteria on open wounds. J Trauma 16:89-94.
23. Flores, A., A. Kingsley. (2007). Topical antimicrobial dressings: an overview. Wound Essentials 2:182-185.
24. Vazquez, J. A. (2006). The emerging problem of infectious diseases: The impact of antimicrobial resistance in wound care. Wounds S11:1-9.
25. Waldrop, R. D., C. Prejean, and R. Singleton. (1998). Overuse of parenteral antibiotics for wound care in an urban emergency department. Am J Emerg Med 16:343-345.
26. Keast, D. H., and H. Orsted. (1998). The basic principles of wound care. Ostomy Wound Manage 44:24-28, 30-31.
27. Yager, D. R., R. A. Kulina, and L. A. Gilman. (2007). Wound fluids: A window into the wound environment? Int J Low Extrem Wounds 6:262-272.
28. Burton, C. S. (1991). Practical management of leg ulcers. South Med J 84:2-17.
29. Margolis, D. J., J. A. Berlin, and B. L. Strom. (1999). Risk factors associated with the failure of a venous leg ulcer to heal. Arch Dermatol 135:920-926.
30. Steed, D. L., D. P. Hill, M. E. Woodske, W. G. Payne, and M. C. Robson. (2006). Woundhealing trajectories as outcome measures of venous stasis ulcer treatment. Int Wound J 3:40-47.
31. Margolis, D. J., L. Allen-Taylor, O. Hoffstad, J. A. Berlin. (2005). Healing diabetic neuropathic foot ulcers: Are we getting better? Diabet Med 22:172-176.
32. Pound, N., S. Chipchase, K. Treece, F. Game, W. Jeffcoate. (2005). Ulcer-free survival following management of foot ulcers in diabetes. Diabet Med 22:1306-1309.
33. Beitz J. M., J. Fey, and D. O’Brien. (1998). Perceived need for education vs. actual knowledge of pressure ulcer care in a hospital nursing staff. Medsurg Nurs 7:293-301.
34. Vermeulen, H., D. Ubbink, S. Schreuder, and M. Lubbers. (2006). Inter- and intraobserver (dis)agreement among physicians and nurses as to the choice of dressings in surgical patients with open wounds. Wounds 18:286-293.
35. Bux, M., and J. S. Malhi. (1996). Assessing the use of dressings in practice. J Wound Care 5:305-308.
36. Graham I. D., M. B. Harrison, M. Shafey, and D. Keast. (2003). Knowledge and attitudes regarding care of leg ulcers. Can Fam Physician 49:896-902.
37. Flanagan, M., L. Rotchell, J. Fletcher, and J. Schofield. (2001). Community nurses’, home carers’ and patients’ perceptions of factors affecting venous leg ulcer recurrence and management of services. J Nurs Manag 9:153-159.
38. Boulton, A. J. (2004). Pressure and the diabetic foot: clinical science and offloading techniques. Am J Surg 187:17S-24S.
39. Bolton, L., L. Corbett L, and L. Bernato, et al. (2006). Development of a content-validated venous ulcer guideline. Ostomy Wound Manage 52:32-48.
40. Van Hecke, A., M. Grypdonck, and T. Defloor. (2008). Interventions to enhance patient compliance with leg ulcer treatment: A review of the literature. J Clin Nurs 17:29-39.
41. Heinen, M. M., C. van der Vleuten, and M. J. de Rooij, et al. (2007). Physical activity and adherence to compression therapy in patients with venous leg ulcers. Arch Dermatol 143:1283-1288.
42. Mudge, E., N. Ivins, W. Simmonds, and P. Price. (2007). Adherence to a 2-layer compression system for chronic venous ulceration. Br J Nurs 16:S4, S6, S8.
43. Association for the Advancement of Wound Care. (2006). Summary algorithm for venous ulcer care with annotations of available evidence. Retrieved January 26, 2008 from:http://www.aawconline.org/pdf/Algorithm%20for%20Venous%20Ulcer%20Care.pdf.
44. Royal College of Nursing. (2006). The nursing management of patients with venous leg ulcers. Recommendations. Retrieved January 26, 2009 from: http://www.rcn.org. uk/__data/assets/pdf_file/0003/107940/003020.pdf.
45. Clark, M. (2003). Barriers to the implementation of clinical guidelines. J Tissue Viability 13:62-64, 66, 68.
46. Helberg, D., E. Mertens, R. J. Halfens, T. Dassen. (2006). Treatment of pressure ulcers:Results of a study comparing evidence and practice. Ostomy Wound Manage 52:60-72.
47. Paquay, L., R. Wouters, T. Defloor, F. Buntinx, R. Debaillie, and L. Geys. (2008). Adherence to pressure ulcer prevention guidelines in home care: A survey of current practice. J Clin Nurs 17:627-636.
48. Jones, K. R., K. Fennie, and A. Lenihan. (2007). Evidence-based management of chronic wounds. Adv Skin Wound Care 20:591-600.
49. Marchionni, C., and J. Ritchie. (2008). Organizational factors that support the implementation of a nursing best practice guideline. J Nurs Manag 16:266-274.
50. Salcido, R. (2002). AHCPR clinical practice guidelines, a decade later. Adv Skin Wound Care 15:52,54.
51. Shekelle, P. G., E. Ortiz, and S. Rhodes, et al. Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: How quickly do guidelines become outdated? JAMA 286:1461-1467.
52. Levine, J. M., M. Peterson, and F. Savino. (2005). Implementing the new CMS guidelines for wound care: Areas for potential citations explained. Nurs Homes 54:110.
53. Hess, C. T. (2008). Developing a wound care compliance program (Parts 1 and 2). Adv Skin Wound Care 21:496,544.
54. Fife, C., D. Walker, B. Thomson, and M. Carter. (2007). Limitations of daily living activities in patients with venous stasis ulcers undergoing compression bandaging:Problems with the concept of self-bandaging. Wounds 19:255-257.
55. Kluger, J. (2008). Simplexity: Why simple things become complex (and how complex things can be made simple). New York: Hyperion.
56. Cullen, B., L. Morrison, and P. Watt (2000). Mechanism of action of a next generation wound treatment. Paper presented at First Wound Healing Congress, September 12, Melbourne, Australia.
57. Motta, G., G. B. Ratto, and A. De Barbieri, et al. (1983). Can heterologous collagen enhance the granulation tissue growth? An experimental study. Ital J Surg Sci 13:101-108.
58. Nagata, H., H. Ueki, and T. Moriguchi. (1985). Fibronectin. Localization in normal human skin, granulation tissue, hypertrophic scar, mature scar, progressive systemic sclerotic skin, and other fibrosing dermatoses. Arch Dermatol 121:995-999.
59. Veves, A., P. Sheehan, and H. T. Pham. (2002). A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg 137:822-827.
60. Ghatnekar, O., M. Willis, and U. Persson. (2002). Cost-effectiveness of treating deep diabetic foot ulcers with Promogran in four European countries. J Wound Care 11:70-74.
61. Kakagia, D. D., K. J. Kazakos, and K. C. Xarchas, et al. (2007). Synergistic action of protease-modulating matrix and autologous growth factors in healing of diabetic foot ulcers. A prospective randomized trial. J Diabetes Complications 21:387-391.
62. Nisi, G., C. Brandi, L. Grimaldi, M. Calabrò, and C. D’Aniello. (2005). Use of a protease- modulating matrix in the treatment of pressure sores. Chir Ital 57:465-468.
63. Vin, F., L. Teot, and S. Meaume. (2002). The healing properties of Promogran in venous leg ulcers. J Wound Care 11:335-341.
64. Kakagia, D. D., K. J. Kazakos, and K. C. Xarchas, et al. (2007). Synergistic action of protease-modulating matrix and autologous growth factors in healing of diabetic foot ulcers. A prospective randomized trial. J Diabetes Complications 21:387-391.
65. Harding, K. G., H. L. Morris, and G. K. Patel. (2002). Science, medicine and the future:Healing chronic wounds. BMJ 324:160-163.
66. Stojadinovic, A., J. W. Carlson, G. S. Schultz, T. A. Davis, and E. A. Elster. (2008). Topical advances in wound care. Gynecol Oncol 111:S70-S80.
67. Wieman, T. J., J. M. Smiell, and Y. Su. (1998). Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebocontrolled double-blind study. Diabetes Care 21:822-827.
68. Hunter, J. E., L. Teot, R. Horch, and P. E. Banwell. (2007). Evidence-based medicine:vacuum-assisted closure in wound care management. Int Wound J 4:256-269.
69. Thompson, J. T., and M. W. Marks. (2007). Negative pressure wound therapy. Clin Plast Surg 34:673-684.
70. Webb, L. X., and H. C. Pape. (2008). Current thought regarding the mechanism of action of negative pressure wound therapy with reticulated open cell foam. J Orthop Trauma 22:S135-S137.
71. Carter, M. J. and R. A. Warriner III. (2009). Evidence-based medicine in wound care:time for a new paradigm. Adv Skin Wound Care 22:12,14-16.
72. Britton, A., M. McKee, N. Black, K. McPherson, C. Sanderson, and C. Bain. (1998). Threats to applicability of randomised trials: Exclusions and selective participation. Health Technol Assess 2:1-124.
73. Carter, M. J., C. E. Fife, D. Walker, and B. Thomson. (2009). Estimating the applicability of wound-care randomized controlled trials to general wound care populations by estimating the percentage of individuals excluded from a typical wound care population in such trials. Adv Skin Wound Care 22:316-324.
74. Benson, K., and A. J. Hartz. (2000). A comparison of observational studies and randomized, controlled trials. N Engl J Med 342:1878-1886.
75. Concato, J., N. Shah, R. I. Horwitz. (2000). Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342:1887-1892.
76. Ioannidis, J. P., A. B. Haidich, and M. Pappa, et al. (2001). Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 286:821-830.
77. McKee, M., A. Britton, N. Black, K. McPherson, C. Sanderson, C. Bain. (1999). Methods in health services research. Interpreting the evidence: choosing between randomised and non-randomised studies. BMJ 319:312-315.
78. Shikata, S., T. Nakayama, Y. Noguchi, Y. Taji, and H. Yamagishi. (2006). Comparison of effects in randomized controlled trials with observational studies in digestive surgery. Ann Surg 244:668-676.
79. Dooley, J., G. King, and B. Slade. (1997). Establishment of reference pressure of transcutaneous oxygen for the comparative evaluation of problem wounds. Undersea Hyperb Med 24:235-244.
80. Dowd, G. S. E., K. Linge, and G. Bentley. (1983). Measurement of transcutaneous oxygen pressure in normal and ischaemic skin. J Bone Joint Surg 65B:79-83.
81. Hauser, C. J., and W. C. Shoemaker. (1983). Use of transcutaneous PO2 regional perfusion index to quantify tissue perfusion in peripheral vascular disease. Ann Surg 197:337-343.
82. Wipke-Tevis, D. D., N. A. Stotts, D. A. Williams, E. S. Froelicher, and T. K. Hunt. (2001). Tissue oxygenation, perfusion, and position in patients with venous leg ulcers. Nurs Res 50:24-32.
83. Fife, C. E., D. R. Smart, P. J. Sheffield, H. W. Hopf, G. Hawkins, and D. Clarke. (2009). Transcutaneous oximetry in clinical practice: Consensus statements from an expert panel based on evidence. Undersea Hyperb Med 36:43-53.
84. Moffatt, C. J., P. J. Franks, D. C. Doherty, R. Martin, R. Blewett, and F. Ross. (2004). Prevalence of leg ulceration in a London population. Q J Med 97:431-437.
85. Nelzén, O., D. Bergqvist, and A. Lindhagen. (1991). Leg ulcer etiology-A cross sectional population study. J Vasc Surg 14:557-564.
86. Ince, P., D. Kendrick, F. Game, and W. Jeffcoate. (2007) The association between baseline characteristics and the outcome of foot lesions in a UK population with diabetes. Diabet Med 24:977-981.
87. Prompers, L., M. Huijberts, and J. Apelqvist, et al. (2007). High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 50:18-25.
88. Viswanathan, V. (2007). The diabetic foot: Perspectives from Chennai, South India. Int J Low Extrem Wounds 6:34-36.
89. Gray, B. H., M. S. Conte, and M. D. Dake, et al. (2008). Atherosclerotic Peripheral Vascular Disease Symposium II: Lower-extremity revascularization: State of the art. Circulation 118:2864-2872.
90. Ubbink, D. T., G. H. Spincemaille, R. S. Reneman, and M. J. Jacobs. (1999). Prediction of imminent amputation in patients with non-reconstructible leg ischemia by means of microcirculatory investigations. J Vasc Surg 30:114-121.
91. Arora, S., F. Pomposelli, F. W. LoGerfo, and A. Veves. (2002). Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization. J Vasc Surg 35:501-505.
92. Sen, C. K. (2009). Wound healing essentials: Let there be oxygen. Wound Repair Regen 17:1-18.
93. Nikol, S., I. Baumgartner, and E. Van Belle, et al. (2008). Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol Ther 16:972-978.
94. Bishop, J. B., L. G. Phillips, and T. A. Mustoe, et al. (1992). A prospective randomized evaluator-blinded trial of two potential wound healing agents for the treatment of venous stasis ulcers. J Vasc Surg 16:251-257.
95. Blair, S. D., C. M. Backhouse, D. D. I. Wright, E. Riddle, and C. N. McCollum. (1988). Do dressings influence the healing of chronic venous ulcers? Phlebology 3:129-134.
96. Fumal, I., C. Braham, P. Paquet, C. Piérard-Franchimont, and G. E. Piérard. (2002). The beneficial toxicity paradox of antimicrobials in leg ulcer healing impaired by a polymicrobial flora: A proof-of-concept study. Dermatology 204:70-74.
97. Leaper, D. J. (2006). Silver dressings: Their role in wound management. Int Wound J 3:282-294.
98. Lansdown, A. B., A. Williams, S. Chandler, and S. Benfield. (2005). Silver absorption and antibacterial efficiency of silver dressings. J Wound Care 14:155-160.
99. Vermeulen, H., J. M. van Hattem, M. N. Storm-Versloot, and D. T. Ubbink. (2007). Topical silver for treating infected wounds. Cochrane Database Syst Rev 1:CD005486.
100. Chambers, H., J. C. Dumville, and N. Cullum. (2007). Silver treatments for leg ulcers:A systematic review. Wound Repair Regen 15:165-173.
101. Lo, S. F., M. Hayter, C. J. Chang, W. Y. Hu, and L. L. Lee. (2008). A systematic review of silver-releasing dressings in the management of infected chronic wounds. J Clin Nurs 17:1973-1985.
102. Altman, D. G., K. F. Schulz, and D. Moher, et al. (2001). The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 134:663-694.
103. Downs, S. H., and N. Black. (1998). The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 52:377-384.
104. Harbour, R, and J. Miller. (2001). A new system for grading recommendations in evidence based guidelines. BMJ 323:334-336.
105. Atkins, D., D. Best, and P. A. Briss, et al. (2004). Grading quality of evidence and strength of recommendations. BMJ 328:1490.